医学
传染性
效价
血清学
抗体效价
感染控制
中和抗体
抗体
免疫学
病毒学
置信区间
内科学
病毒
重症监护医学
作者
Moriah Bergwerk,Tal Gonen,Yaniv Lustig,Sharon Amit,Marc Lipsitch,Carmit Cohen,Michal Mandelboim,E G Levin,Carmit Rubin,Victoria Indenbaum,Ilana Tal,Malka Zavitan,Neta S. Zuckerman,Adina Bar‐Chaim,Yitshak Kreiss,Gili Regev‐Yochay
标识
DOI:10.1056/nejmoa2109072
摘要
Despite the high efficacy of the BNT162b2 messenger RNA vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), rare breakthrough infections have been reported, including infections among health care workers. Data are needed to characterize these infections and define correlates of breakthrough and infectivity.
科研通智能强力驱动
Strongly Powered by AbleSci AI